The funding agency for basic research had been led by an interim president for more than a year.

The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

Microscopic analysis of charred, shapeless lumps from archaeological sites revealed ancient cereal grains that may have undergone malting to make beer.

Born of researchers’ frustration with not being able to contribute during the pandemic, Crowdfight COVID-19 has matched hundreds of SARS-CoV-2 projects with people who can help.

Mauro Ferrari says the organization’s response to the COVID-19 pandemic is inadequate, but ERC members claim his proposals didn’t align with the mission of the council.

The plan to revitalize the European innovation landscape is entering a transition.

A newly hatched bearded vulture chick is part of an effort to reintroduce the declining species across Europe.

The number of measles cases this year is already more than all of the cases reported in 2018.

Just half of respondents in Eastern Europe agree that vaccines are safe.

The fish continue to spawn over a large area despite a drop in their numbers, a study finds.

Demonstrations took place in the country’s capital on Tuesday following what many researchers see as a threat to academic freedom.

Scientists say that increasingly rigorous licensing procedures have complicated research efforts—and in some cases, stopped experiments completely.

A funder-driven push for freely accessible scholarly literature has divided the scientific community.

Nearly three dozen Nobel laureates and Fields Medal winners sign a letter to the UK Prime Minister and the President of the European Commission.

The WHO reports more than 41,000 cases in the region in the first half of 2018.

A combination of public opposition, intense regulations, and rising costs in the EU make conditions in China and elsewhere attractive for studying monkeys.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

The plan would also allow non-EU countries to pay to participate in EU research programs, albeit without wielding “decisional power.”